{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T10:23:34Z","timestamp":1794306214132,"version":"4.9.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Thyroid tumors represent 1\u20134% of cancers in both dogs and humans. Most canine tumors are follicular (FTC) or medullary carcinomas (MTC), unlike humans, where only 10\u201315% are FTC and 2% are MTC, with BRAF\/NRAS or RET mutations, respectively. Here, we conduct histological and molecular analyses of canine thyroid tumors. Transcriptionally, elevated\n                    <jats:italic>ERBB2<\/jats:italic>\n                    expression characterizes FTC tumors, whereas MTC tumors show upregulated\n                    <jats:italic>RET<\/jats:italic>\n                    signaling. Elevated HER2 protein-staining and larger tumor size associate with shorter progression-free survival. Recurrent mutations are rarely observed with potential driver variants in\n                    <jats:italic>MEN1<\/jats:italic>\n                    (10%),\n                    <jats:italic>KRAS<\/jats:italic>\n                    (7%), and\n                    <jats:italic>TSHR<\/jats:italic>\n                    (3%), among others. Notably, mutations in DNA repair pathway genes are the most consistently shared across tumors, occurring in 60% of cases. Thus, the genomic profile of canine FTC differs significantly from that of humans, with limited reliance on RAS\/RAF signaling for oncogenic progression. Conversely, RET signaling likely underlies tumorigenesis in both canine and human MTC.\n                  <\/jats:p>","DOI":"10.1038\/s42003-025-09225-y","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T15:24:35Z","timestamp":1765034675000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparative genomic and clinicopathological analysis uncovers contrasting molecular profiles of canine and human thyroid carcinomas"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8941-1468","authenticated-orcid":false,"given":"Sunetra","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3939-8963","authenticated-orcid":false,"given":"Samantha N.","family":"Schlemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupa","family":"Idate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Lana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3148-1332","authenticated-orcid":false,"given":"Daniel P.","family":"Regan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8914-7767","authenticated-orcid":false,"given":"Douglas H.","family":"Thamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5310-0078","authenticated-orcid":false,"given":"Dawn L.","family":"Duval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,6]]},"reference":[{"key":"9225_CR1","unstructured":"Vail, D. M., Liptak, J. M., Thamm, D. H. & Editor:, S. Withrow and MacEwen\u2019s Small Animal Clinical Oncology (Saunders, 2020)."},{"key":"9225_CR2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/03009858231177225","volume":"61","author":"JM Athey","year":"2023","unstructured":"Athey, J. M. et al. Canine thyroid carcinomas: a review with emphasis on comparing the compact subtype of follicular thyroid carcinomas and medullary thyroid carcinomas. Vet. Pathol. 61, 7\u201319 (2023).","journal-title":"Vet. Pathol."},{"key":"9225_CR3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1532-950X.1995.tb01336.x","volume":"24","author":"JR Carver","year":"1995","unstructured":"Carver, J. R., Kapatkin, A. & Patnaik, A. K. A comparison of medullary thyroid carcinoma and thyroid adenocarcinoma in dogs: a retrospective study of 38 cases. Vet. Surg. 24, 315\u2013319 (1995).","journal-title":"Vet. Surg."},{"key":"9225_CR4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jcpa.2020.04.002","volume":"177","author":"LMC Soares","year":"2020","unstructured":"Soares, L. M. C. et al. Histopathological and immunohistochemical characteristics of thyroid carcinoma in the dog. J. Comp. Pathol. 177, 34\u201341 (2020).","journal-title":"J. Comp. Pathol."},{"key":"9225_CR5","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.2460\/javma.2000.216.1775","volume":"216","author":"AF Theon","year":"2000","unstructured":"Theon, A. F., Marks, S. L., Feldman, E. S. & Griffey, S. Prognostic factors and patterns of treatment failure in dogs with unresectable differentiated thyroid carcinomas treated with megavoltage irradiation. J. Am. Vet. Med. Assoc. 216, 1775\u20131779 (2000).","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"9225_CR6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/030098588402100206","volume":"21","author":"FM Moore","year":"1984","unstructured":"Moore, F. M., Kledzik, G. S., Wolfe, H. J. & DeLellis, R. A. Thyroglobulin and calcitonin immunoreactivity in canine thyroid carcinomas. Vet. Pathol. 21, 168\u2013173 (1984).","journal-title":"Vet. Pathol."},{"key":"9225_CR7","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jcpa.2016.07.009","volume":"155","author":"JA Ramos-Vara","year":"2016","unstructured":"Ramos-Vara, J. A., Frank, C. B., DuSold, D. & Miller, M. A. Immunohistochemical detection of Pax8 and Napsin A in Canine thyroid tumours: comparison with thyroglobulin, calcitonin and thyroid transcription Factor 1. J. Comp. Pathol. 155, 286\u2013298 (2016).","journal-title":"J. Comp. Pathol."},{"key":"9225_CR8","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1354\/vp.39-4-480","volume":"39","author":"JA Ramos-Vara","year":"2002","unstructured":"Ramos-Vara, J. A., Miller, M. A., Johnson, G. C. & Pace, L. W. Immunohistochemical detection of thyroid transcription factor-1, thyroglobulin, and calcitonin in canine normal, hyperplastic, and neoplastic thyroid gland. Vet. Pathol. 39, 480\u2013487 (2002).","journal-title":"Vet. Pathol."},{"key":"9225_CR9","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/030098589102800504","volume":"28","author":"B Leblanc","year":"1991","unstructured":"Leblanc, B., Parodi, A. L., Lagadic, M., Hurtrel, M. & Jobit, C. Immunocytochemistry of canine thyroid tumors. Vet. Pathol. 28, 370\u2013380 (1991).","journal-title":"Vet. Pathol."},{"key":"9225_CR10","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1111\/jvim.12436","volume":"28","author":"M Campos","year":"2014","unstructured":"Campos, M. et al. Clinical, pathologic, and immunohistochemical prognostic factors in dogs with thyroid carcinoma. J. Vet. Intern. Med 28, 1805\u20131813 (2014).","journal-title":"J. Vet. Intern. Med"},{"key":"9225_CR11","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jama.2023.26348","volume":"331","author":"L Boucai","year":"2024","unstructured":"Boucai, L., Zafereo, M. & Cabanillas, M. E. Thyroid Cancer. J. Am. Med. Assoc. 331, 425\u2013435 (2024).","journal-title":"J. Am. Med. Assoc."},{"key":"9225_CR12","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research, N. Integrated genomic characterization of papillary thyroid carcinoma. Cell 159, 676-690 (2014).","DOI":"10.1016\/j.cell.2014.09.050"},{"key":"9225_CR13","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1172\/JCI85271","volume":"126","author":"I Landa","year":"2016","unstructured":"Landa, I. et al. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J. Clin. Investig. 126, 1052\u20131066 (2016).","journal-title":"J. Clin. Investig."},{"key":"9225_CR14","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1158\/1078-0432.CCR-18-0373","volume":"24","author":"N Pozdeyev","year":"2018","unstructured":"Pozdeyev, N. et al. Genetic analysis of 779 advanced differentiated and anaplastic thyroid cancers. Clin. Cancer Res. 24, 3059\u20133068 (2018).","journal-title":"Clin. Cancer Res."},{"key":"9225_CR15","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1089\/thy.2019.0604","volume":"30","author":"N Pozdeyev","year":"2020","unstructured":"Pozdeyev, N. et al. Comprehensive immune profiling of medullary thyroid cancer. Thyroid 30, 1263\u20131279 (2020).","journal-title":"Thyroid"},{"key":"9225_CR16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41421-022-00479-y","volume":"8","author":"X Shi","year":"2022","unstructured":"Shi, X. et al. Integrated proteogenomic characterization of medullary thyroid carcinoma. Cell Discov. 8, 120 (2022).","journal-title":"Cell Discov."},{"key":"9225_CR17","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1111\/jvim.12435","volume":"28","author":"M Campos","year":"2014","unstructured":"Campos, M. et al. Upregulation of the PI3K\/Akt pathway in the tumorigenesis of canine thyroid carcinoma. J. Vet. Intern. Med. 28, 1814\u20131823 (2014).","journal-title":"J. Vet. Intern. Med."},{"key":"9225_CR18","doi-asserted-by":"publisher","unstructured":"Yu, Y. et al. Deleterious mutations in the TPO gene associated with familial thyroid follicular cell carcinoma in Dutch German Longhaired Pointers. Genes 12. https:\/\/doi.org\/10.3390\/genes12070997 (2021).","DOI":"10.3390\/genes12070997"},{"key":"9225_CR19","volume":"23","author":"Y Yu","year":"2022","unstructured":"Yu, Y., Manders, F., Grinwis, G. C. M., Groenen, M. A. M. & Crooijmans, R. A recurrent somatic missense mutation in GNAS gene identified in familial thyroid follicular cell carcinomas in German longhaired pointer dogs. BMC Genom. 23, 669 (2022).","journal-title":"BMC Genom."},{"key":"9225_CR20","doi-asserted-by":"crossref","first-page":"E2031","DOI":"10.1210\/jc.2012-2092","volume":"97","author":"A Boichard","year":"2012","unstructured":"Boichard, A. et al. Somatic RAS mutations occur in a large proportion of sporadic RET-negative medullary thyroid carcinomas and extend to a previously unidentified exon. J. Clin. Endocrinol. Metab. 97, E2031\u20132035 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9225_CR21","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1089\/thy.2017.0318","volume":"28","author":"VD Yakushina","year":"2018","unstructured":"Yakushina, V. D., Lerner, L. V. & Lavrov, A. V. Gene fusions in thyroid cancer. Thyroid 28, 158\u2013167 (2018).","journal-title":"Thyroid"},{"key":"9225_CR22","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1093\/hmg\/ddu749","volume":"24","author":"JW Kunstman","year":"2015","unstructured":"Kunstman, J. W. et al. Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing. Hum. Mol. Genet. 24, 2318\u20132329 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"9225_CR23","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2460\/javma.1995.206.07.1007","volume":"206","author":"MK Klein","year":"1995","unstructured":"Klein, M. K. et al. Treatment of thyroid carcinoma in dogs by surgical resection alone: 20 cases (1981-1989). J. Am. Vet. Med. Assoc. 206, 1007\u20131009 (1995).","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"9225_CR24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2460\/javma.241.1.95","volume":"241","author":"JL Tuohy","year":"2012","unstructured":"Tuohy, J. L., Worley, D. R. & Withrow, S. J. Outcome following simultaneous bilateral thyroid lobectomy for treatment of thyroid gland carcinoma in dogs: 15 cases (1994-2010). J. Am. Vet. Med. Assoc. 241, 95\u2013103 (2012).","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"9225_CR25","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2460\/javma.256.4.444","volume":"256","author":"AN Frederick","year":"2020","unstructured":"Frederick, A. N. et al. Outcomes for dogs with functional thyroid tumors treated by surgical excision alone. J. Am. Vet. Med. Assoc. 256, 444\u2013448 (2020).","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"9225_CR26","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.cvsm.2007.03.008","volume":"37","author":"LG Barber","year":"2007","unstructured":"Barber, L. G. Thyroid tumors in dogs and cats. Vet. Clin. North Am. Small Anim. Pract. 37, 755\u2013773 (2007).","journal-title":"Vet. Clin. North Am. Small Anim. Pract."},{"key":"9225_CR27","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1751-0813.2005.tb11650.x","volume":"83","author":"AJ Worth","year":"2005","unstructured":"Worth, A. J., Zuber, R. M. & Hocking, M. Radioiodide (I-131) therapy for the treatment of canine thyroid carcinoma. Aust. Vet. J. 83, 208\u2013214 (2005).","journal-title":"Aust. Vet. J."},{"key":"9225_CR28","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1476-5829.2011.00275.x","volume":"10","author":"C London","year":"2012","unstructured":"London, C. et al. Preliminary evidence for biologic activity of toceranib phosphate (Palladia(\u00ae)) in solid tumours. Vet. Comp. Oncol. 10, 194\u2013205 (2012).","journal-title":"Vet. Comp. Oncol."},{"key":"9225_CR29","first-page":"994","volume":"52","author":"ME Nadeau","year":"2011","unstructured":"Nadeau, M. E. & Kitchell, B. E. Evaluation of the use of chemotherapy and other prognostic variables for surgically excised canine thyroid carcinoma with and without metastasis. Can. Vet. J. 52, 994\u2013998 (2011).","journal-title":"Can. Vet. J."},{"key":"9225_CR30","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1001\/jamaoncol.2020.3362","volume":"6","author":"A Maniakas","year":"2020","unstructured":"Maniakas, A. et al. Evaluation of overall survival in patients with anaplastic thyroid carcinoma, 2000-2019. JAMA Oncol. 6, 1397\u20131404 (2020).","journal-title":"JAMA Oncol."},{"key":"9225_CR31","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.860671","volume":"13","author":"I Puliafito","year":"2022","unstructured":"Puliafito, I. et al. Target therapy in thyroid cancer: current challenge in clinical use of tyrosine kinase inhibitors and management of side effects. Front. Endocrinol. 13, 860671 (2022).","journal-title":"Front. Endocrinol."},{"key":"9225_CR32","doi-asserted-by":"publisher","unstructured":"McInnes, L., Healy, J. & Melville, J. Umap: uniform manifold approximation and projection for dimension reduction. https:\/\/doi.org\/10.48550\/arXiv.1802.03426 (2018).","DOI":"10.48550\/arXiv.1802.03426"},{"key":"9225_CR33","doi-asserted-by":"publisher","unstructured":"Minna, E. et al. Medullary thyroid carcinoma mutational spectrum update and signaling-type inference by transcriptional profiles: literature meta-analysis and study of tumor samples. Cancers 14. https:\/\/doi.org\/10.3390\/cancers14081951 (2022).","DOI":"10.3390\/cancers14081951"},{"key":"9225_CR34","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1200\/JCO.2018.77.8738","volume":"36","author":"A Wolff","year":"2018","unstructured":"Wolff, A. et al. Human epidermal growth factor receptor 2 testing in breast cancer: American Society Of Clinical Oncology\/College of American Pathologists clinical practice guideline focused update. J. Clin. Oncol. 36, 2105\u20132122 (2018).","journal-title":"J. Clin. Oncol."},{"key":"9225_CR35","doi-asserted-by":"crossref","first-page":"993","DOI":"10.5858\/arpa.2023-0950-SA","volume":"147","author":"AC Wolff","year":"2023","unstructured":"Wolff, A. C. et al. Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\u2013College of American Pathologists Guideline Update. Arch. Pathol. Lab Med. 147, 993\u20131000 (2023).","journal-title":"Arch. Pathol. Lab Med."},{"key":"9225_CR36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/0300985813509388","volume":"51","author":"L Pena","year":"2014","unstructured":"Pena, L. et al. Canine mammary tumors: a review and consensus of standard guidelines on epithelial and myoepithelial phenotype markers, HER2, and hormone receptor assessment using immunohistochemistry. Vet. Pathol. 51, 127\u2013145 (2014).","journal-title":"Vet. Pathol."},{"key":"9225_CR37","doi-asserted-by":"publisher","unstructured":"Das, S., Idate, R., Cronise, K., Gustafson, D. & Duval, D. Identifying candidate druggable targets in canine cancer cell lines using whole-exome sequencing. Mol. Cancer Ther. 18. https:\/\/doi.org\/10.1158\/1535-7163.MCT-18-1346 (2019).","DOI":"10.1158\/1535-7163.MCT-18-1346"},{"key":"9225_CR38","doi-asserted-by":"publisher","unstructured":"Mahato, A. K. & Sidorova, Y. A. RET receptor tyrosine kinase: role in neurodegeneration, obesity, and cancer. Int. J. Mol. Sci. 21. https:\/\/doi.org\/10.3390\/ijms21197108 (2020).","DOI":"10.3390\/ijms21197108"},{"key":"9225_CR39","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nature24042","volume":"550","author":"J-Y Hsu","year":"2017","unstructured":"Hsu, J.-Y. et al. Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15. Nature 550, 255\u2013259 (2017).","journal-title":"Nature"},{"key":"9225_CR40","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0960-9822(07)00422-8","volume":"8","author":"Y Enokido","year":"1998","unstructured":"Enokido, Y. et al. GFR alpha-4 and the tyrosine kinase Ret form a functional receptor complex for persephin. Curr. Biol. 8, 1019\u20131022 (1998).","journal-title":"Curr. Biol."},{"key":"9225_CR41","doi-asserted-by":"publisher","unstructured":"Perez-Baena, M. J., Cordero-Perez, F. J., Perez-Losada, J. & Holgado-Madruga, M. The role of GAB1 in cancer. Cancers 15. https:\/\/doi.org\/10.3390\/cancers15164179 (2023).","DOI":"10.3390\/cancers15164179"},{"key":"9225_CR42","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94\u2013101 (2020).","journal-title":"Nature"},{"key":"9225_CR43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4314\/ovj.v6i3.10","volume":"6","author":"EA Arias","year":"2016","unstructured":"Arias, E. A., Castillo, V. A. & Aristarain, M. E. Calcitonin-negative primary neuroendocrine tumor of the thyroid (nonmedullary) in a dog. Open Vet. J. 6, 223\u2013227 (2016).","journal-title":"Open Vet. J."},{"key":"9225_CR44","first-page":"61","volume":"83","author":"I Leav","year":"1976","unstructured":"Leav, I., Schiller, A. L., Rijnberk, A., Legg, M. A. & der Kinderen, P. J. Adenomas and carcinomas of the canine and feline thyroid. Am. J. Pathol. 83, 61\u2013122 (1976).","journal-title":"Am. J. Pathol."},{"key":"9225_CR45","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5326\/0460249","volume":"46","author":"KL Wucherer","year":"2010","unstructured":"Wucherer, K. L. & Wilke, V. Thyroid cancer in dogs: an update based on 638 Cases (1995-2005). J. Am. Anim. Hosp. Assoc. 46, 249\u2013254 (2010).","journal-title":"J. Am. Anim. Hosp. Assoc."},{"key":"9225_CR46","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.2460\/javma.1986.188.10.1160","volume":"188","author":"J Harari","year":"1986","unstructured":"Harari, J., Patterson, J. S. & Rosenthal, R. C. Clinical and pathologic features of thyroid tumors in 26 dogs. J. Am. Vet. Med Assoc. 188, 1160\u20131164 (1986).","journal-title":"J. Am. Vet. Med Assoc."},{"key":"9225_CR47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/j.ctsap.2007.03.007","volume":"22","author":"JM Liptak","year":"2007","unstructured":"Liptak, J. M. Canine thyroid carcinoma. Clin. Tech. Small Anim. Pr. 22, 75\u201381 (2007).","journal-title":"Clin. Tech. Small Anim. Pr."},{"key":"9225_CR48","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12020-019-02183-6","volume":"67","author":"G Costante","year":"2020","unstructured":"Costante, G. & Meringolo, D. Calcitonin as a biomarker of C cell disease: recent achievements and current challenges. Endocrine 67, 273\u2013280 (2020).","journal-title":"Endocrine"},{"key":"9225_CR49","volume":"19","author":"C Gambardella","year":"2019","unstructured":"Gambardella, C. et al. Calcitonin negative medullary thyroid carcinoma: a challenging diagnosis or a medical dilemma?. BMC Endocr. Disord. 19, 45 (2019).","journal-title":"BMC Endocr. Disord."},{"key":"9225_CR50","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1440-1827.2006.01959.x","volume":"56","author":"P Zhang","year":"2006","unstructured":"Zhang, P. et al. Immunohistochemical analysis of thyroid-specific transcription factors in thyroid tumors. Pathol. Int. 56, 240\u2013245 (2006).","journal-title":"Pathol. Int."},{"key":"9225_CR51","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/path.5997","volume":"258","author":"JT Kim","year":"2022","unstructured":"Kim, J. T. et al. Adrenomedullin2 stimulates progression of thyroid cancer in mice and humans under nutrient excess conditions. J. Pathol. 258, 264\u2013277 (2022).","journal-title":"J. Pathol."},{"key":"9225_CR52","doi-asserted-by":"crossref","first-page":"45776","DOI":"10.18632\/oncotarget.10166","volume":"7","author":"AM Makhlouf","year":"2016","unstructured":"Makhlouf, A. M. et al. Identification of CHEK1, SLC26A4, c-KIT, TPO and TG as new biomarkers for human follicular thyroid carcinoma. Oncotarget 7, 45776\u201345788 (2016).","journal-title":"Oncotarget"},{"key":"9225_CR53","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1746-6148-8-67","volume":"8","author":"BK Urie","year":"2012","unstructured":"Urie, B. K., Russell, D. S., Kisseberth, W. C. & London, C. A. Evaluation of expression and function of vascular endothelial growth factor receptor 2, platelet derived growth factor receptors-alpha and -beta, KIT, and RET in canine apocrine gland anal sac adenocarcinoma and thyroid carcinoma. BMC Vet. Res. 8, 67 (2012).","journal-title":"BMC Vet. Res."},{"key":"9225_CR54","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-015-1955-9","volume":"15","author":"K Kasaian","year":"2015","unstructured":"Kasaian, K. et al. The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy. BMC Cancer 15, 984 (2015).","journal-title":"BMC Cancer"},{"key":"9225_CR55","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrc3680","volume":"14","author":"LM Mulligan","year":"2014","unstructured":"Mulligan, L. M. RET revisited: expanding the oncogenic portfolio. Nat. Rev. Cancer 14, 173\u2013186 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"9225_CR56","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/cncr.28661","volume":"120","author":"GW Krampitz","year":"2014","unstructured":"Krampitz, G. W. & Norton, J. A. RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma. Cancer 120, 1920\u20131931 (2014).","journal-title":"Cancer"},{"key":"9225_CR57","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e02004","volume":"5","author":"S Yoshimoto","year":"2019","unstructured":"Yoshimoto, S. et al. Immunohistochemical evaluation of HER2 expression in canine thyroid carcinoma. Heliyon 5, e02004 (2019).","journal-title":"Heliyon"},{"key":"9225_CR58","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.1038\/sj.onc.1203972","volume":"19","author":"D Yu","year":"2000","unstructured":"Yu, D. & Hung, M. C. Overexpression of ErbB2 in cancer and ErbB2-targeting strategies. Oncogene 19, 6115\u20136121 (2000).","journal-title":"Oncogene"},{"key":"9225_CR59","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.humpath.2017.05.007","volume":"65","author":"D Nonaka","year":"2017","unstructured":"Nonaka, D. A study of FoxA1 expression in thyroid tumors. Hum. Pathol. 65, 217\u2013224 (2017).","journal-title":"Hum. Pathol."},{"key":"9225_CR60","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-24836-9","volume":"12","author":"BA Alsaihati","year":"2021","unstructured":"Alsaihati, B. A. et al. Canine tumor mutational burden is correlated with TP53 mutation across tumor types and breeds. Nat. Commun. 12, 4670 (2021).","journal-title":"Nat. Commun."},{"key":"9225_CR61","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/ng.3557","volume":"48","author":"J Kim","year":"2016","unstructured":"Kim, J. et al. Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors. Nat. Genet. 48, 600\u2013606 (2016).","journal-title":"Nat. Genet."},{"key":"9225_CR62","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1101\/gr.226845.117","volume":"28","author":"B Meier","year":"2018","unstructured":"Meier, B. et al. Mutational signatures of DNA mismatch repair deficiency in C. elegans and human cancers. Genome Res. 28, 666\u2013675 (2018).","journal-title":"Genome Res."},{"key":"9225_CR63","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/GIM.0b013e3181be5c97","volume":"11","author":"A Falchetti","year":"2009","unstructured":"Falchetti, A. et al. Multiple endocrine neoplasia type 1 (MEN1): not only inherited endocrine tumors. Genet Med. 11, 825\u2013835 (2009).","journal-title":"Genet Med."},{"key":"9225_CR64","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1124\/molpharm.124.000743","volume":"106","author":"MB Dwyer","year":"2024","unstructured":"Dwyer, M. B., Aumiller, J. L. & Wedegaertner, P. B. Going Rogue: mechanisms, regulation, and roles of mutationally activated galpha in human cancer. Mol. Pharm. 106, 198\u2013215 (2024).","journal-title":"Mol. Pharm."},{"key":"9225_CR65","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-24812-3","volume":"12","author":"J van Riet","year":"2021","unstructured":"van Riet, J. et al. The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets. Nat. Commun. 12, 4612 (2021).","journal-title":"Nat. Commun."},{"key":"9225_CR66","doi-asserted-by":"publisher","unstructured":"Santoro, M., Moccia, M., Federico, G. & Carlomagno, F. RET gene fusions in malignancies of the thyroid and other tissues. Genes 11. https:\/\/doi.org\/10.3390\/genes11040424 (2020).","DOI":"10.3390\/genes11040424"},{"key":"9225_CR67","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/jvim.16644","volume":"37","author":"D Enache","year":"2023","unstructured":"Enache, D. et al. Thyroidectomy in dogs with thyroid tumors: survival analysis in 144 cases (1994-2018). J. Vet. Intern Med. 37, 635\u2013647 (2023).","journal-title":"J. Vet. Intern Med."},{"key":"9225_CR68","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5326\/15473317-34-2-109","volume":"34","author":"LS Fineman","year":"1998","unstructured":"Fineman, L. S., Hamilton, T. A., de Gortari, A. & Bonney, P. Cisplatin chemotherapy for treatment of thyroid carcinoma in dogs: 13 cases. J. Am. Anim. Hosp. Assoc. 34, 109\u2013112 (1998).","journal-title":"J. Am. Anim. Hosp. Assoc."},{"key":"9225_CR69","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2460\/javma.255.8.926","volume":"255","author":"JK Reagan","year":"2019","unstructured":"Reagan, J. K. et al. Complications and outcomes associated with unilateral thyroidectomy in dogs with naturally occurring thyroid tumors: 156 cases (2003-2015). J. Am. Vet. Med. Assoc. 255, 926\u2013932 (2019).","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"9225_CR70","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00428-008-0644-3","volume":"453","author":"A Gama","year":"2008","unstructured":"Gama, A., Alves, A. & Schmitt, F. Identification of molecular phenotypes in canine mammary carcinomas with clinical implications: application of the human classification. Virchows Arch. 453, 123\u2013132 (2008).","journal-title":"Virchows Arch."},{"key":"9225_CR71","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1177\/1040638714527289","volume":"26","author":"H Shinoda","year":"2014","unstructured":"Shinoda, H. et al. Significance of ER alpha, HER2, and CAV1 expression and molecular subtype classification to canine mammary gland tumor. J. Vet. Diagn. Investig. 26, 390\u2013403 (2014).","journal-title":"J. Vet. Diagn. Investig."},{"key":"9225_CR72","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.tvjl.2007.10.013","volume":"180","author":"WL Hsu","year":"2009","unstructured":"Hsu, W. L., Huang, H. M., Liao, J. W., Wong, M. L. & Chang, S. C. Increased survival in dogs with malignant mammary tumours overexpressing HER-2 protein and detection of a silent single nucleotide polymorphism in the canine HER-2 gene. Vet. J. 180, 116\u2013123 (2009).","journal-title":"Vet. J."},{"key":"9225_CR73","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.7314\/APJCP.2012.13.12.6415","volume":"13","author":"A Muhammadnejad","year":"2012","unstructured":"Muhammadnejad, A., Keyhani, E., Mortazavi, P., Behjati, F. & Haghdoost, I. S. Overexpression of her-2\/neu in malignant mammary tumors; translation of clinicopathological features from dog to human. Asian Pac. J. Cancer Prev. 13, 6415\u20136421 (2012).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"9225_CR74","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.rvsc.2012.09.016","volume":"94","author":"L Ressel","year":"2013","unstructured":"Ressel, L. et al. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome. Res. Vet. Sci. 94, 299\u2013305 (2013).","journal-title":"Res. Vet. Sci."},{"key":"9225_CR75","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1292\/jvms.20-0483","volume":"83","author":"K Sakai","year":"2021","unstructured":"Sakai, K. et al. ErbB2 copy number gain is associated with adverse outcome in canine mammary carcinoma. J. Vet. Med. Sci. 83, 370\u2013377 (2021).","journal-title":"J. Vet. Med. Sci."},{"key":"9225_CR76","doi-asserted-by":"publisher","unstructured":"Megquier, K. et al. BarkBase: epigenomic annotation of canine genomes. Genes 10. https:\/\/doi.org\/10.3390\/genes10060433 (2019).","DOI":"10.3390\/genes10060433"},{"key":"9225_CR77","unstructured":"Kiupel, M., Capen, C., Miller, M. & Smedley, R. Histological classification of the endocrine system of domestic animals. WHO International Histological Classification of Tumors of Domestic Animals. Washington, DC: Armed Forces Institute of Pathology, 25\u201339 (2008)."},{"key":"9225_CR78","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/0300985818817024","volume":"56","author":"M Tsuboi","year":"2019","unstructured":"Tsuboi, M. et al. Assessment of HER2 expression in canine urothelial carcinoma of the urinary bladder. Vet. Pathol. 56, 369\u2013376 (2019).","journal-title":"Vet. Pathol."},{"key":"9225_CR79","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"9225_CR80","volume":"24","author":"JRS Meadows","year":"2023","unstructured":"Meadows, J. R. S. et al. Genome sequencing of 2000 canids by the Dog10K consortium advances the understanding of demography, genome function and architecture. Genome Biol. 24, 187 (2023).","journal-title":"Genome Biol."},{"key":"9225_CR81","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"9225_CR82","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1093\/bioinformatics\/bty896","volume":"35","author":"R Vera Alvarez","year":"2019","unstructured":"Vera Alvarez, R., Pongor, L. S., Marino-Ramirez, L. & Landsman, D. TPMCalculator: one-step software to quantify mRNA abundance of genomic features. Bioinformatics 35, 1960\u20131962 (2019).","journal-title":"Bioinformatics"},{"key":"9225_CR83","doi-asserted-by":"crossref","first-page":"11.10.11","DOI":"10.1002\/0471250953.bi1110s43","volume":"43","author":"GA Van der Auwera","year":"2013","unstructured":"Van der Auwera, G. A. et al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr. protoc. Bioinform. 43, 11.10.11\u201333 (2013).","journal-title":"Curr. protoc. Bioinform."},{"key":"9225_CR84","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation 2, 100141 (2021).","journal-title":"Innovation"},{"key":"9225_CR85","volume":"20","author":"BJ Haas","year":"2019","unstructured":"Haas, B. J. et al. Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods. Genome Biol. 20, 213 (2019).","journal-title":"Genome Biol."},{"key":"9225_CR86","volume":"2","author":"MC Wagle","year":"2018","unstructured":"Wagle, M. C. et al. A transcriptional MAPK Pathway Activity Score (MPAS) is a clinically relevant biomarker in multiple cancer types. NPJ Precis. Oncol. 2, 7 (2018).","journal-title":"NPJ Precis. Oncol."},{"key":"9225_CR87","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1073\/pnas.0900780106","volume":"106","author":"CA Pratilas","year":"2009","unstructured":"Pratilas, C. A. et al. V600E)BRAF is associated with disabled feedback inhibition of RAF-MEK signaling and elevated transcriptional output of the pathway. Proc. Natl. Acad. Sci. USA 106, 4519\u20134524 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9225_CR88","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09373-w","volume":"10","author":"J Plassais","year":"2019","unstructured":"Plassais, J. et al. Whole genome sequencing of canids reveals genomic regions under selection and variants influencing morphology. Nat. Commun. 10, 1489 (2019).","journal-title":"Nat. Commun."},{"key":"9225_CR89","doi-asserted-by":"publisher","unstructured":"Chakravarty, D. et al. OncoKB: a precision oncology knowledge base. JCO Precis. Oncol. 2017. https:\/\/doi.org\/10.1200\/PO.17.00011 (2017).","DOI":"10.1200\/PO.17.00011"},{"key":"9225_CR90","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/bioinformatics\/btt182","volume":"29","author":"HA Shihab","year":"2013","unstructured":"Shihab, H. A., Gough, J., Cooper, D. N., Day, I. N. & Gaunt, T. R. Predicting the functional consequences of cancer-associated amino acid substitutions. Bioinformatics 29, 1504\u20131510 (2013).","journal-title":"Bioinformatics"},{"key":"9225_CR91","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1002\/cncr.31245","volume":"124","author":"MN Nikiforova","year":"2018","unstructured":"Nikiforova, M. N. et al. Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules. Cancer 124, 1682\u20131690 (2018).","journal-title":"Cancer"},{"key":"9225_CR92","doi-asserted-by":"publisher","unstructured":"Blokzijl, F., Janssen, R., van Boxtel, R. & Cuppen, E. MutationalPatterns: comprehensive genome-wide analysis of mutational processes. Genome Med. 10. https:\/\/doi.org\/10.1186\/s13073-018-0539-0 (2018).","DOI":"10.1186\/s13073-018-0539-0"},{"key":"9225_CR93","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.gpb.2020.02.001","volume":"18","author":"P Jia","year":"2020","unstructured":"Jia, P. et al. MSIsensor-pro: fast, accurate, and matched-normal-sample-free detection of microsatellite instability. Genom. Proteom. Bioinform. 18, 65\u201371 (2020).","journal-title":"Genom. Proteom. Bioinform."},{"key":"9225_CR94","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/annonc\/mdu479","volume":"26","author":"F Favero","year":"2015","unstructured":"Favero, F. et al. Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data. Ann. Oncol. 26, 64\u201370 (2015).","journal-title":"Ann. Oncol."},{"key":"9225_CR95","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847\u20132849 (2016).","journal-title":"Bioinformatics"},{"key":"9225_CR96","doi-asserted-by":"crossref","unstructured":"Wickham, H. Ggplot2: elegant graphics for data analysis. (Springer, 2009).","DOI":"10.1007\/978-0-387-98141-3"},{"key":"9225_CR97","doi-asserted-by":"publisher","unstructured":"Das, S. & Schlemmer, S. Source data for plots in: comparative genomic and clinicopathological analysis uncovers contrasting molecular profiles of canine and human thyroid carcinomas. Figshare. https:\/\/doi.org\/10.6084\/m9.figshare.30389557.v1 (2025).","DOI":"10.6084\/m9.figshare.30389557.v1"},{"key":"9225_CR98","doi-asserted-by":"publisher","unstructured":"Das, S. Cross-Species Amino Acid Position Mapping: From Dog to Human. Zenodo. https:\/\/doi.org\/10.5281\/zenodo.17363451 (2025).","DOI":"10.5281\/zenodo.17363451"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09225-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09225-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09225-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T22:05:36Z","timestamp":1767477936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09225-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,6]]},"references-count":98,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9225"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-09225-y","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,6]]},"assertion":[{"value":"18 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}